chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: HEPA, MNQ, PPV, TDAP
Symptoms: Pyrexia, Rash erythematous
Clinical narrative: Case number PHHY2013US110822 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 496881) website on 04 OCT 2013. This report refers to 18-years-old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: M11071) and PNEUMOVAX (batch number: 0709AE), both intramuscularly in the left arm on 15 JUL 2013. On the same date, he also received VAQTA (batch number: H019104) and BOOSTRIX (batch number: AC52B099CA) in the right arm intramuscularly. On the same date, after vaccinations he developed fever but he did not have a thermometer to take his temperature. It was reported that he felt very hot and developed pink 1/2 inch rash on the left arm. He took ibuprofen and showed some improvement. The final outcome of the events reported as recovered. The causality and seriousness of the events were not reported.  Following an internal review on 15 OCT 2013, a significant correction was done for the information received on 04 OCT 2013. The event feeling hot which was a stand alone diagnosis initially was kept as a symptom to the event pyrexia.
Age: 11.0
Sex: M
Vaccine: HPVX, MNQ, TDAP
Symptoms: Injection site reaction, Rash pustular, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Case number PHHY2013US117217 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 497230) on 15 OCT 2013. This report refers to an 11-year-old male patient. His medical history included allergic rhinitis and concomitant medications were not reported. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported hence conservatively taken as MENVEO IN, human papilloma virus vaccine (other manufacturer, batch number: not reported) and diphtheria tetanus acellular pertussis vaccine (other manufacturer, batch number not reported) on 17 JUL 2013. On 18 JUL 2013, he experienced significant swelling and erythema at site of vaccination of left arm with pustular rash development. He went to emergency room, The outcome of the events was reported as condition unchanged as on 19 JUL 2013.
Sex: F
Vaccine: MNQ
Symptoms: Injection site rash, Injection site warmth
Clinical narrative: Case number PHHY2013US110833 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (reference number: 497257) on 04 OCT 2013. This report refers to an 18-year-old female patient. Her medical history was not reported. Her concomitant medication included Tretinoin 0.1% cream. She was vaccinated with MENVEO (batch number: M11041) intramuscularly in to the left arm on 16 JUL 2013. On 27 JUL 2013, she experienced rash and warm feeling at the site of injection. Final outcome of the events was reported as condition unchanged as on 21 JUL 2013. No further information about seriousness and causality was provided.
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Urticaria
Clinical narrative: Case number PHHY2013US110857 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (reference number: 497591) on 04 OCT 2013. This report refers to a 17-year-old female patient. Her medical history was not reported. Her concomitant medication included oral contraceptives. She was vaccinated with MENVEO (batch number M12129) intramuscularly in to the left arm on 22 JUL 2013. On 23 JUL 2013, she experienced redness, heat and swelling at the injection site. She also developed hives on the left arm. Final outcome of the events was reported as condition unchanged as on 25 JUL 2013. No further information about seriousness and causality was provided.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site rash, Injection site swelling, Pain in extremity
Clinical narrative: Case number PHHY2013US110731 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 497615) website on 04 OCT 2013. This report refers to a 11-year-old male patient. His current condition included eczema for which he received Elocon ointment. He was vaccinated with MENVEO (batch number X12006) in the right upper arm which progressed on arm only. The patient visited the emergency room. The outcome of the events reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Case number PHHY2013US127708 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 498035) website on 11 NOV 2013. This report refers to an 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M12094) in to the right arm along with ADACEL (other manufacturer, batch number: C4170AA) in to the left arm on 17 JUL 2013. On 21 JUL 2013, he experienced a rash at the right deltoid injection site that was described as red, slightly raised, blotchy and slightly itchy. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2013US127714, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498239) website on 11 NOV 2013. This report refers to a 12-year-old male patient. He was vaccinated with MENVEO (batch number: M12027) in the right arm and VAQTA (batch number J002347) in the left arm, both intramuscularly on 25 JUL 2013. On the same day, in the night after vaccination, his right arm had slight swelling, redness and was warm to touch. The outcome of the events reported as not recovered. The seriousness and causality of the events were not reported.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2013US110763 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498251) website on 04 OCT 2013. This report refers to 11-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: A12123) intramuscularly in the left arm on 30 JUL 2013. On 31 JUL 2013, she experienced left arm redness, hot and swelling of area 4x3 inches. She visited the emergency room. The event outcome was reported as completely recovered. The seriousness and causality of the events were not reported. No additional information was available.
Sex: M
Vaccine: HPVX, MNQ, TDAP
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Case number PHHY2013US117223 is an initial report received via Vaccine Adverse Event Reporting System (VAERS reference number: 498379) on 15 OCT 2013. This report refers to an 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported hence conservatively taken as MENVEO INN, human papilloma virus vaccine (other manufacturer and batch number: not reported) and diphtheria tetanus acellular pertussis vaccine (0thr manufacturer, batch number: not reported) on 31 JUL 2013. On 02 AUG 2013, he experienced warmth, swelling and erythema of 5x5x3 cm size on bilateral upper extremities at site of vaccination. He went to emergency room. The outcome of the events was reported  as condition unchanged.
Age: 16.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Case number PHHY2013US127763 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 498407) website on 11 NOV 2013. This report refers to a 16-years-old female patient. Her medical history was not reported and her concomitant medications included AMOXIL. Her vaccination history included administration of first dose of MENVEO (batch number: not reported) on 26 JUN 2009 which was well tolerated. She was vaccinated with second dose of MENVEO (batch number: A12131 intramuscularly in the right arm and GARDASIL (other manufacturer, batch number: J00264) intramuscularly in the left arm on 30 JUL 2013. ON 31 JUL 2013, she complained of a five and half centimeter round erythematous area with itching on lower deltoid area. The outcome of the events was reported as condition unchanged.
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site inflammation
Clinical narrative: Case number PHHY2013US110768 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (reference number: 498449) on 04 OCT 2013. The report refers to an 11-year-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with MENVEO (batch number A12094 along with ADACEL (other manufacturer, batch number; C4250AA). GARDASIL (other manufacturer, batch number: H021608) and HAVRIX (other manufacturer, batch number: AHAVB677AB) on 29 JUL 2013. MENVEO and ADACEL were given in to the right arm and GARDASIL and HAVRIX were given in the left arm. All the vaccines were administered intramuscularly. On 31 JUL 2013, he had redness and inflammation on his right deltoid that measure 80 mm. Final outcome of the events was reported as complete recovery on an unknown date. No further information about seriousness and causality was provided.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Headache, Pain, Skin warm
Clinical narrative: Case number PHHY2013US110784 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (reference number: 498772) on 04 Oct 2013: This report refers to a 21-year-old female patient. Her medical history included allergy to penicillin. Her concomitant medication was not reported. She was vaccinated with MENVEO (batch number: M12092) intramuscularly in to the left arm on 06 Aug 2013. On the same day after vaccination she complained of feeling achy, weak, she experienced headache, she did not have fever, and her body temperature was 97 Fahrenheit. Her mother stated she always had reactions to vaccines, but this time it was more severe, when she called clinic to report complaints. Final outcome of the events was reported as condition unchanged as on 07 Aug 2013. No further information about seriousness and causality was provided.
Age: 12.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Case number PHHY2013US110892 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 498777) website on 04 Oct 2013. This report refers to a 12-year-old male patient. His medical history and concomitant medication were not reported. On 29 Jul 2013, he was vaccinated with MENVEO, (batch number: X12093) intramuscularly into right arm, HAVRIX, (batch number: AHAVB690CA) intramuscularly into right arm. Concomitantly he was also vaccinated with GARDASIL, (batch number: H017698) intramuscularly into left arm, ADACEL, (batch number: V4421AA) intramuscularly into left arm and VARIVAX, (batch number: J001181) subcutaneously into the left arm on 29 Jul 2013. On 30 Jul 2013, he experienced large warm red area and hard area on his right deltoid. The outcomes of these events were reported as condition unchanged as of 07 Aug 2013. The causality and seriousness of the events were not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Erythema, Skin warm
Clinical narrative: Case number PHHY2013US110905 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 498876) website on 04 Oct 2013. This report refers to an 11-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: A12132) intramuscularly, BOOSTRIX (other manufacturer, batch number: not reported) subcutaneously and VARIVAX (other manufacturer, batch number: H016737) subcutaneously on 05 Aug 2013. On 06 Aug 2013, she experienced a large red and warm area on her right deltoid, measuring 3 inches by 3 inches in size. The outcomes of these events were reported as complete recovery. The causality and seriousness of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Pain in extremity, Skin warm
Clinical narrative: Case number PHHY2013US116582 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 498914) wbsite on 15 Oct 2013. This case refers to 11-year-old male patient. He was vaccinated meningococcal vaccine (unknown manufacturer: batch number: not reported, so conservatively coded as MENVEO INN) and TDAP (batch number: not reported, other manufacturer) intramuscularly on 06 Aug 2013. On 06 Aug 2013, after the vaccination, the patient developed large arm redness, swelling, warmth and pain requiring return appointment for concerns for infection. The outcome of events was reported as not yet recovered as of 08 Aug 2013. The seriousness and causality of events was not reported.
Age: 33.0
Sex: F
Vaccine: HEP, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2013US110911, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 499048) website on 04 Oct 2013. This report refers to a 33-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: M12131) intramuscularly into left arm, ENGERIX-B (other manufacturer, batch number: AHBVC095CA) intramuscularly into right arm and BOOSTRIX (other manufacturer, batch number: ZR45M) intramuscularly into right on 07 Aug 2013. On 09 Aug 2013, she experienced red, swollen, hot and raised area around injection site (unspecified arm), approximately 2 inches in diameter. The outcomes of these events were reported as condition unchanged as of 11 Aug 2013. The seriousness and causality of the event were not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Local reaction
Clinical narrative: Case number PHHY2013US17659 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499246) website on 11 Nov 2013: This report refers to a 12-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: unknown) intramuscularly in to the right arm along with a TDAP (manufacturer and batch number: unknown) intramuscularly in to the left arm on 02 Aug 2013. On the same day after vaccination, he experienced a large red local reaction on the right arm. Final outcome of the event was reported as complete recovery. No further information about seriousness and causality was reported.
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Hypersensitivity, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2013US127796 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499677) website on 11 NOV 2013. This report refers to a 12-year-old female patient. Her medical history included allergy to strawberries, tomatoes and KEFLEX. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A11051) intramuscularly in to the left arm along with VAQTA (other manufacturer, batch number: H014278) intramuscularly. GARDASIL (other manufacturer, batch number: H012608) intramuscularly in to the right arm, BOOSTRIX (other manufacturer, batch number: AC52B81BA) intramuscularly in to the right arm and with VARIVAX (other manufacturer, batch number J001182) subcutaneously in to the left arm on 12 AUG 2013, her mother called up the pharmacy to stated that the patient experienced an allergic reaction to the vaccine given in the back of her left arm. Her mother stated that the symptoms were tenderness to the area of injection, redness, swelling, and the area was warm to touch. Final outcome of the events was reported as condition unchanged as on 13 AUG 2013. No further information about seriousness and causality was reported.
Age: 18.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Case number PHHY2013US127808 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499748) website on 11 Nov 2013: This report refers to an 18-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12009) intramuscularly along with BOOSTRIX (other manufacturer, batch number: AC52B081BA) subcutaneously on 14 Aug 2013. On 15 Aug 2013, he experienced severe headache, chills, fatigue and fever (unsure of the values). On 15 Aug 2013, he went to urgent care and was then sent to the emergency room (ER) by urgent care physician. On 15 Aug 2013 he was released from ER after five to six hours while he was feeling better. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: Case number PHHY2013US127815 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499765) website on 11 Nov 2013: This report refers to an 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M12123) in to the left arm on 22 Jul 2013. On the same day after vaccination, his upper arm was red and swollen and his arm was itchy. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Rash, Rash erythematous
Clinical narrative: Case number PHHY2013US12782 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 49796) website on 11 Nov 2013: This report refers to an 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: X1216) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B092FA) intramuscularly in to the left arm and with HAVRIX (other manufacturer, batch number: AHAVB356A) intramuscularly in to the right arm on 14 Aug 2013. On 15 Aug 2013, he had large red swollen bumps on both arms. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2013US127828 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499797) website on 11 NOV 2013. This report refers to a 12-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11052) in to the left arm along with GARDASIL (other manufacturer, batch number H017698) in to the right arm and with ADACEL (other manufacturer, batch number: U4383AA) on 14 AUG 2013. On an unknown date after vaccinations he experienced fever of 103.9 degree Celsius and was treated with MOTRIN  at 400 mg every six to eight hours. Final outcome of the event was reported as condition unchanged as on 15 AUG 2013. No further information about seriousness and causality was reported.
Age: 34.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site pain, Pyrexia
Clinical narrative: Case number PHHY2013US127833 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499827) website on 11 Nov 2013: This report refers to a 34-year-old male patient. His medical history included allergy to PERCOCET. His concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12009) intramuscularly in to the left arm on 12 Aug 2013. On the same day after vaccination he experienced pain at injection site and fever that kept increasing till 16 Aug 2013 (values not reported). He was advised to visit the Emergency Room (ER) and was suggested to see a physician if the reaction persisted. Final outcome of the events was reported as condition unchanged as on 16 Aug 2013. No further information about seriousness and causality was reported.
Age: 15.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2013US127772 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 499926) web site on 11 Nov 2013. This report refers to a 15-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO, (batch number: M12092) intramuscularly in the right arm and HAVRIX, (batch number: YG4XA) intramuscularly in the left arm on 14 Aug 2013. On 14 Aug 2013 he experienced severe swelling in right upper arm, redness, pain and tenderness from right shoulder to right elbow. His right upper arm increased in size by an estimate of 50 percent. He went to emergency room. The outcome of the events was reported as complete recovery.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHEH2013US017044 is an initial spontaneous report received from a nurse on 08 Aug 2013, and with a follow up report received on 13 Aug 2013. This report refers to an 11-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M12123) in the left arm at a dose of 0.5 ml on 07 Aug 2013. On the same day, he experienced left upper arm injection site swelling, itchy, red and pain. The outcome of the event was unknown. No further information was provided. Follow up report received from nurse on 13 Aug 2013. Updated vaccination and event onset date. Added event injection site pain.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Middle insomnia, Vaccination site pain
Clinical narrative: Case number PHEH2013US017044 is an initial spontaneous report received from a nurse on 08 Aug 2013, and with a follow up report received on 13 Aug 2013. This report refers to an 11-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M12123) in the left arm at a dose of 0.5 ml on 07 Aug 2013. On the same day, he experienced left upper arm injection site swelling, itchy, red and pain. The outcome of the event was unknown. No further information was provided. Follow up report received from nurse on 13 Aug 2013. Updated vaccination and event onset date. Added event injection site pain.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHEH2013US017044 is an initial spontaneous report received from a nurse on 08 Aug 2013, and with a follow up report received on 13 Aug 2013. This report refers to an 11-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M12123) in the left arm at a dose of 0.5 ml on 07 Aug 2013. On the same day, he experienced left upper arm injection site swelling, itchy, red and pain. The outcome of the event was unknown. No further information was provided. Follow up report received from nurse on 13 Aug 2013. Updated vaccination and event onset date. Added event injection site pain.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2013US127816 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499985) website on 11 NOV 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with the MENVEO (batch number: M12123) intramuscularly in the right arm and GARDASIL (other manufacturer, batch number: H021346) intramuscularly in the left arm on 07 AUG 2013. On the same date she had pain in the vaccination site (right arm). She woke up during night due to increased pain. In arm there was an 8/8 large area of swelling over the right deltoid and it was hand sized. The site was warm. She took ALEVE and applied ice. it was reported that the swelling became worse in evening. She took ibuprofen and continued keeping ice. She woke up on 09 AUG 2013 with decreased swelling with an oral area 4 inches long and 3 inches wide. It was reported that the reddish area around the vaccination site was 2 inches in diameter. She was instructed to continue with cold pack for 20 minutes and then off for an hour. She was also given 1% hydrocortisone twice daily for pain. The outcome of the event was reported as complete recovery.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Middle insomnia, Vaccination site pain
Clinical narrative: Case number PHHY2013US127816 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499985) website on 11 NOV 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with the MENVEO (batch number: M12123) intramuscularly in the right arm and GARDASIL (other manufacturer, batch number: H021346) intramuscularly in the left arm on 07 AUG 2013. On the same date she had pain in the vaccination site (right arm). She woke up during night due to increased pain. In arm there was an 8/8 large area of swelling over the right deltoid and it was hand sized. The site was warm. She took ALEVE and applied ice. it was reported that the swelling became worse in evening. She took ibuprofen and continued keeping ice. She woke up on 09 AUG 2013 with decreased swelling with an oral area 4 inches long and 3 inches wide. It was reported that the reddish area around the vaccination site was 2 inches in diameter. She was instructed to continue with cold pack for 20 minutes and then off for an hour. She was also given 1% hydrocortisone twice daily for pain. The outcome of the event was reported as complete recovery.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2013US127816 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499985) website on 11 NOV 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with the MENVEO (batch number: M12123) intramuscularly in the right arm and GARDASIL (other manufacturer, batch number: H021346) intramuscularly in the left arm on 07 AUG 2013. On the same date she had pain in the vaccination site (right arm). She woke up during night due to increased pain. In arm there was an 8/8 large area of swelling over the right deltoid and it was hand sized. The site was warm. She took ALEVE and applied ice. it was reported that the swelling became worse in evening. She took ibuprofen and continued keeping ice. She woke up on 09 AUG 2013 with decreased swelling with an oral area 4 inches long and 3 inches wide. It was reported that the reddish area around the vaccination site was 2 inches in diameter. She was instructed to continue with cold pack for 20 minutes and then off for an hour. She was also given 1% hydrocortisone twice daily for pain. The outcome of the event was reported as complete recovery.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHEH2013US017436 is an initial spontaneous report received from a nurse on 13 Aug 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant  medication were not reported. She was vaccinated with MENVEO (batch number: M12123) intramuscularly on 07 Aug 2013. On the same day (at 6 pm), she experienced injection site swelling and pain. The outcome, seriousness and causality were not reported.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Middle insomnia, Vaccination site pain
Clinical narrative: Case number PHEH2013US017436 is an initial spontaneous report received from a nurse on 13 Aug 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant  medication were not reported. She was vaccinated with MENVEO (batch number: M12123) intramuscularly on 07 Aug 2013. On the same day (at 6 pm), she experienced injection site swelling and pain. The outcome, seriousness and causality were not reported.
Age: 12.0
Sex: F
Vaccine: MNQ, HPV4, MNQ, MNQ
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHEH2013US017436 is an initial spontaneous report received from a nurse on 13 Aug 2013. This report refers to a 12-year-old female patient. Her medical history and concomitant  medication were not reported. She was vaccinated with MENVEO (batch number: M12123) intramuscularly on 07 Aug 2013. On the same day (at 6 pm), she experienced injection site swelling and pain. The outcome, seriousness and causality were not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Body temperature increased, Injection site erythema, Injection site pain, Injection site swelling, Local reaction
Clinical narrative: Case number PHHY2013US127851 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 500358) web site on 11 Nov 2013. This report refers to a 12-year-old male patient. His medical history included idiopathic thrombocytopenic purpura (ITP) and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11047) and BOOSTRIX (other manufacturer, batch number: AC52B081AA); both vaccines administered intramuscularly in the right arm on 21 Aug 2013. On 22 Aug 2013, he complained of swelling and redness in right upper arm and it was tender to touch. His skin was intact. He had a temperature of 99.8 degree. He was told that it was a local reaction and was advised to keep ice with home treatment and to monitor for increased pain and swelling. He was also suggested to seek MD care if the events worsened. The outcome of the events was reported as condition unchanged.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Injection site pruritus, Local reaction, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2013US127869 is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 500514) web site on 11 NOV 2013. This report refers to a 12-year-old male patient. His medical history included facial swelling due to shell fish allergy and asthma controlled with medications. His concomitant medications included Albuterol nebulizer. He was vaccinated with MENVEO (batch number: M11047) and GARDASIL (other manufacturer, batch number: H021608) both vaccines administered intramuscularly in the right arm and VARIVAX (other manufacturer, batch number H02107) subcutaneously in the left arm and BOOSTRIX (other manufacturer, batch number: AC52B081AA) intramuscularly in the left arm on 21 AUG 2013. His mother called and reported that he had local reaction of right arm. The arm was red and raised and swelling increased on 25 AUG 2013. The reported diameter of local reaction was 2 inches and it was warm to touch. He denied pain. He was afebrile and had normal  range of motion. His skin was intact and there were no red streaks on right arm. It was reported that the site was itchy. His mother applied home treatment with ice for 2 days, but redness and swelling worsened on 26 OCT 2013. He was not given any oral OTC medications. His mother would continue keeping ice and applying  hydrocortisone to the site. His mother was advised to seek MD care if there was no relief. The outcome of the events was reported as condition unchanged.
Sex: F
Vaccine: FLUN4, MNQ, TDAP
Symptoms: Urticaria
Clinical narrative: Case number PHHY2013US127874 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 500527) web site on 11 Nov 2013. This report refers to an 11-years-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A12102) and BOOSTRIX (other manufacturer, batch number: YJ475) both vaccines administered intramuscularly and FLUMIST (other manufacturer, batch number: BH2174) via intranasal route on 16 Aug 2013. ON 16 Aug 2013, she had hives on full body. She went to emergency room and was treated with steroids for 5 days. The outcome of the events was reported as complete recovery.
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Rash, Rash erythematous, Rash macular
Clinical narrative: Case number PHHY2013US127872 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 500841) website on 11 NOV 2013. This report refers to an 11-year-old female patient. She was vaccinated with MENVEO (batch number: M12125) intramuscularly, GARDASIL (other manufacturer, batch number: H021608) intramuscularly and BOOSTRX (other manufacturer, batch number: AC52B090AA) intramuscularly into right arm on 20 AUG 2013. On 25 AUG 2013, she experienced pinkish red rash on legs, arms and abdomen which was not raised, not itching, non-diffuse but with blotchy rash. Outcome of the events was reported as not recovered as of 28 AUG 2013. No seriousness and causality was reported for these events.
Age: 2.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2013US127875 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 500842) website on 11 Nov 2013: This report refers to a 2-year-old female infant. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: X12125) intramuscularly along with BOOSTRIX (batch number: B092AA) intramuscularly and with VARIVAX (batch number: H018783) subcutaneously on 26 Aug 2013. All the vaccines were administered in to the right arm. On the same day after vaccinations she experienced swelling and redness of the right upper arm. Final outcome of the events was reported as condition unchanged as on 28 Aug 2013. No further information about seriousness and causality was reported.
Age: 24.0
Sex: F
Vaccine: MNQ, TD
Symptoms: Diarrhoea, Purging, Vomiting projectile
Clinical narrative: Case number PHHY2013US135280 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 500847) website on 25 Nov 2013. This report refers to a 24-year-old female patient. Her medical history included skin sensitivity to paraben. She was vaccinated with meningococcal vaccine (manufacturer and batch number, hence conservatively coded as MENVEO INN) into right arm and TD (manufacturer and batch unknown) into left arm on 30 Jul 2013. On 31 Jul 2013, she had severe gastrointestinal purging with projectile vomiting and diarrhea for about 8 hours. She was unable to keep even saltines down until 8pm (18.5 hours). It was reported that others in family had eaten exact same meals all day (only difference was vaccines). Outcome of the events was reported as recovered. No seriousness and causality was reported for the events.
Sex: U
Vaccine: MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2013US140059 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 501089) website on 03 Dec 2013. This report refers to a patient of an unknown age and gender. Medical condition of the patient included allergic to diphenhydramine. The patient was vaccinated with MENVEO (batch number: A12119) intramuscularly into left arm on 19 Aug 2013. On 21 Aug 2013, the patient experienced swollen arm that was red and hot to the touch. The patient went to emergency room due to these events and outcome of the events was reported as recovered. No seriousness and causality was reported for the events.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Urticaria, Vaccination site reaction, Vaccination site warmth
Clinical narrative: Case number PHHy2013US140072 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501151) website on 03 Dec 2013. This report refers to an 11-year-old female patient. She was vaccinated with MENVEO (batch number: M12113) into right arm on 21 Aug 2013. On the same day, after vaccination, she had three inches welts on the arm at the site of vaccination which was warm to touch. Outcome of the events was reported as not recovered. No seriousness and causality was reported for the events.
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2013US140101 is an initial spontaneous report receive from Vaccine Adverse Event Reporting System (reference number: 501209) website on 03 Dec 2013: This report refers to a 14-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A11082) intramuscularly in to the left arm on 31 Aug 2013. On 01 Sep 2013, he developed red, swollen, and hot area directly below injection site which was approximately 4x3 inches. He visited the emergency room following these events. Final outcome of the events was reported as complete recovery on an undetermined date. No further information about causality and seriousness was reported.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Case number PHHy2013US140106 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501223) website on 03 Dec 2013. This report refers to an 11-year-old female patient. Her medical history included peanut allergy and eczema. She was vaccinated with MENVEO (batch number: A12102) into left arm on 23 Aug 2013. On 25 Aug 2013, she experienced 12 cm x 11 cm erythema and 9 cm x 10 cm induration at site of injection. Outcome of the events was reported as recovered. No seriousness and causality of the events were reported.
Age: 17.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: Case number PHHY2013US140536 is an initial spontaneous report received from the vaccine adverse event reporting system (VAERS reference number: 501282) website on 03 Dec 2013. This report refers to a 17-years-old female patient. She did not have any drug allergies or reactions and there was no medical history. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: not reported), VARIVAX (other manufacturer, batch number: J003704) subcutaneously and ADACEL (other manufacturer, batch number, not reported) on 14 Aug 2013 when she was pregnant. Her last menstrual period (LMP), estimated due date (EDD) and date of conception were not provided. She delivered a baby on 16 Aug 2013 and both mother and baby was fine. No laboratory tests and treatment were given were done. No adverse events were reported.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Erythema, Pain, Peripheral swelling, Ultrasound scan normal
Clinical narrative: Case number PHHY2013US127892 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501293) website on 11 Nov 2013: This report refers to an 11-year-old male patient. His medical history was not reported. His concomitant medications included CONCERTA, ZYRTEC and MIRALAX. He was vaccinated with MENVEO (batch number: M12121) along with HAVRIX (other manufacturer, batch number: JR737) 29 Aug 2013. Both the vaccines were given intramuscularly in to the left arm. On 30 Aug 2013 after vaccination, he began having redness and soreness. It worsened throughout the day and his mom called at 5:00 pm and stated that his entire tricep was swollen. At this clinic was closed, therefore he was sent to Emergency Room (ER). They got an ultrasound done to rule out abscess. Ultrasound results were negative for abscess. He started on cephalexin and was advised to return clinic on 31 Aug 2013 for follow up checkup. Swelling was no better but had not worsened. He was afebrile and felt fine. He was advised to continue course of antibiotics. Final outcome of the events was reported as condition unchanged as on 04 Sep 2013. No further information about seriousness and causality was reported.
Age: 11.0
Sex: M
Vaccine: DTP, MNQ
Symptoms: Erythema, Tenderness
Clinical narrative: Case number PHHY2013US140116 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501494) website on 03 Dec 2013. This report refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: A12118) into right arm and DTP vaccine (other manufacturer, batch number: U4612AA) into right arm on 24 Jul 2013. On 26 Jul 2013, he experienced redness and tenderness at deltoid area. Outcome of the events was reported as not recovered as of 04 Sep 2013. No seriousness and causality was reported for the events.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: Case number PHEH2013US018589, is an initial spontaneous report received from a nurse on 30 Aug 2013, with a follow-up received on 30 Aug 2013: This case refers to a 19 years old female patient. She was vaccinated with MENVEO (batch number: A12095, expiry date: Aug 2014), intramuscularly on 07 Aug 2013. The reporter stated that, the patient was pregnant when she received MENVEO dose. No adverse reaction was reported. Follow-up was received on 30 Aug 2013: Expiry date of vaccine was updated.
Age: 17.0
Sex: F
Vaccine: HEP, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Case number PHHY2013US127902 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501694) website on 11 Nov 2013: This report refers to a 17-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12094) along with ENGERIX B (other manufacturer, batch number: AHBVC188CA), IPV (other manufacturer, batch number: H1452), MMR II (other manufacturer, batch number: H012133), BOOSTRIX (other manufacturer, batch number: AC528099CA) and with VARIVAX (other manufacturer, batch number: H018758) on 29 Aug 2013. MENVEO, BOOSTRIX and VARIVAX were administered in to the left arm. ENGERIX B, polio vaccine and MMR II were given in to the right arm. MENVEO, BOOSTRIX and ENGERIX B were given intramuscularly. The remaining vaccines were given subcutaneously. On the same day after vaccinations, she experienced fever of 38-39 degrees Celsius and swelling of right hand. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Age: 14.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2013US127918 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 501868) website on 11 NOV 2013. This report refers to a 14-year-old male patient. His medical history included mood disorder, anxiety and  migraines. His current illness at the time of vaccination included ear canal abrasion. His concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12130) intramuscularly in to the right arm along with GARDASIL (other manufacturer, batch number: H021861) intramuscularly in to the left arm on 07 SEP 2013. ON the same day after vaccinations, he experienced pain, swelling, erythema, itching and tenderness in a 12x18  cm area around the injection site (left upper arm). He was responding well to intramuscular ceftriaxone. He visited the emergency room (ER) following these events. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was reported.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Case number PHHY2013US135490 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 502128) website on 25 Nov 2013. This report refers to a 20-year-old female patient. She was vaccinated with meningococcal vaccine (manufacturer and batch number unknown) intramuscularly into left arm on 07 Sep 2013. She experienced soreness at the injection site immediately after injection followed by itchiness and redness surrounding the injection site within 24 hours from the time of vaccination (08 Sep 2013). The redness increased in size after 24 hours from time of injection hence sought consultation at the Student Health Center. Outcome of the events was reported as not recovered as of 11 Sep 2013. No seriousness and causality was reported for the events.
Sex: M
Vaccine: FLU3, MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2013US127696 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 502192) website on 11 Nov 2013. This report refers to a 12-year-old male patient. His medical history included vomiting with eggs in the past and current condition included allergic rhinitis. His concomitant medication included FLONASE. His vaccination history included administration of FLUZONE (other manufacturer, batch number unknown) last year which was well tolerated. He was vaccinated with MENVEO (batch number: M12119) intramuscularly into left arm and FLUARIX (other manufacturer, batch number: J2B32) intramuscularly into left arm on 06 Sep 2013. He had no initial reaction following injections. However, overnight, he developed significant swelling, erythema, induration, and warmth to the left upper arm and shoulder around the area of injection. He was not weeping or drainage and had no fever. He denied of shortness of breath, wheezing/coughing, facial swelling mouth tingling and vomiting/diarrhea. Outcome of the events was reported as recovered. No seriousness and causality was reported for the events.